180 related articles for article (PubMed ID: 11237218)
1. Insulin resistance in polycystic ovary syndrome: progress and paradoxes.
Venkatesan AM; Dunaif A; Corbould A
Recent Prog Horm Res; 2001; 56():295-308. PubMed ID: 11237218
[TBL] [Abstract][Full Text] [Related]
2. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.
Dunaif A; Xia J; Book CB; Schenker E; Tang Z
J Clin Invest; 1995 Aug; 96(2):801-10. PubMed ID: 7635975
[TBL] [Abstract][Full Text] [Related]
3. The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome.
Corbould A; Dunaif A
Metabolism; 2007 May; 56(5):716-22. PubMed ID: 17445549
[TBL] [Abstract][Full Text] [Related]
4. Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome.
Corbould A; Zhao H; Mirzoeva S; Aird F; Dunaif A
Diabetes; 2006 Mar; 55(3):751-9. PubMed ID: 16505239
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling.
Corbould A; Kim YB; Youngren JF; Pender C; Kahn BB; Lee A; Dunaif A
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E1047-54. PubMed ID: 15613682
[TBL] [Abstract][Full Text] [Related]
6. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS).
Dunaif A; Wu X; Lee A; Diamanti-Kandarakis E
Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E392-9. PubMed ID: 11440917
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
8. Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome.
Wu XK; Zhou SY; Liu JX; Pöllänen P; Sallinen K; Mäkinen M; Erkkola R
Fertil Steril; 2003 Oct; 80(4):954-65. PubMed ID: 14556818
[TBL] [Abstract][Full Text] [Related]
9. [Genetic aspects of polycystic ovary syndrome].
Jakubowski L
Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
Corbould A
Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
[TBL] [Abstract][Full Text] [Related]
11. [Tyrosine phosphorylation and protein expression of insulin receptor substrate-2 in the adipose tissue from patients with polycystic ovary syndrome].
Qiu HY; Chu YL; Li M; Sun YY; Li HF
Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):116-9. PubMed ID: 15840293
[TBL] [Abstract][Full Text] [Related]
12. Selective insulin resistance in the polycystic ovary syndrome.
Book CB; Dunaif A
J Clin Endocrinol Metab; 1999 Sep; 84(9):3110-6. PubMed ID: 10487672
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance.
Ciaraldi TP; Aroda V; Mudaliar S; Chang RJ; Henry RR
J Clin Endocrinol Metab; 2009 Jan; 94(1):157-63. PubMed ID: 18854391
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of insulin resistance in women with PCOS via reduced insulin receptor substrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery.
Seow KM; Juan CC; Hsu YP; Hwang JL; Huang LW; Ho LT
Hum Reprod; 2007 Apr; 22(4):1003-10. PubMed ID: 17204522
[TBL] [Abstract][Full Text] [Related]
15. Genetic contributions to glucose intolerance in polycystic ovary syndrome.
Ehrmann DA
Reprod Biomed Online; 2004 Jul; 9(1):28-34. PubMed ID: 15257813
[TBL] [Abstract][Full Text] [Related]
16. Expression of insulin-receptor substrate-1 and -2 in ovaries from women with insulin resistance and from controls.
Wu X; Sallinen K; Anttila L; Mäkinen M; Luo C; Pöllänen P; Erkkola R
Fertil Steril; 2000 Sep; 74(3):564-72. PubMed ID: 10973656
[TBL] [Abstract][Full Text] [Related]
17. Molecular & genetic factors contributing to insulin resistance in polycystic ovary syndrome.
Mukherjee S; Maitra A
Indian J Med Res; 2010 Jun; 131():743-60. PubMed ID: 20571162
[TBL] [Abstract][Full Text] [Related]
18. Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators.
Li M; Youngren JF; Dunaif A; Goldfine ID; Maddux BA; Zhang BB; Evans JL
J Clin Endocrinol Metab; 2002 Sep; 87(9):4088-93. PubMed ID: 12213853
[TBL] [Abstract][Full Text] [Related]
19. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus.
Dunaif A
Am J Med; 1995 Jan; 98(1A):33S-39S. PubMed ID: 7825639
[TBL] [Abstract][Full Text] [Related]
20. Lack of insulin resistance in fibroblasts from subjects with polycystic ovary syndrome.
Ciaraldi TP; Morales AJ; Hickman MG; Odom-Ford R; Yen SS; Olefsky JM
Metabolism; 1998 Aug; 47(8):940-6. PubMed ID: 9711989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
